Sartorius AG (XTER:SRT)
€ 179.6 -0.4 (-0.22%) Market Cap: 13.73 Bil Enterprise Value: 17.64 Bil PE Ratio: 58.42 PB Ratio: 4.51 GF Score: 88/100

Q1 2022 Sartorius AG Earnings Call Transcript

Apr 21, 2022 / 01:30PM GMT
Release Date Price: €331.5 (+1.38%)
Operator

Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the Q1 2022 Results. Today's conference is being recorded. At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead.

Joachim Kreuzburg
Sartorius Stedim Biotech S.A. - Chairman & CEO

Thank you very much, and also a good day and welcome from my side to our Q1 call for both Sartorius AG as well as Sartorius Stedim Biotech. As always, we would like to start with highlighting some of the key achievements and results of the first quarter, then Rainer will walk you through the key numbers, P&L, et cetera, for the Sartorius Group, and then I will take over again for outlook as well as for Sartorius Stedim Biotech.

And before we start with the highlights, I would like to remind everybody that some of the following statements are related to the future, and therefore, of course, are based on some assumptions, so that we can't take a guarantee for any of such future-oriented statements.

So let's start talking about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot